REZIPRES
Live / Registered — Registered (as of 02 May 2023)
What this means for you
Registered since 02 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90060774
- Registration number
- 7043502
- Mark type
- Stylized text
- Filed
- 19 Jul 2020
- Published for opposition
- 17 Nov 2020
- Registered
- 02 May 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension
Owner
- Dr. Reddy's Laboratories S.A., Basel, CH
- Dr. Reddy's Laboratories S.A., Basel, CH
- Eton Pharmaceuticals, Inc., Deer Park, IL, US
- Eton Pharmaceuticals, Inc., Deer Park, IL, US
Prosecution history
- 04 Jun 2024 — WITHDRAWAL OF ATTORNEY GRANTED
- 04 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 02 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Sept 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Sept 2022 — NON-FINAL ACTION E-MAILED
- 29 Sept 2022 — SU - NON-FINAL ACTION - WRITTEN
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE